Mild Cognitive Impairment study: Circadian-Effective Light vs Rhythmic Light
Official title Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients
ClinicalTrials.gov ID: NCT05016219
What this study is testing
- What it's testing
- The study wants to see whether a specific light pattern (40 Hz rhythmic light) changes brain function, sleep or cognition in mild cognitive impairment.
- Who it's for
- Adults who have been diagnosed with mild cognitive impairment.
- What's involved
- Participants are randomly placed into one of four light groups and sit in front of the light for two hours each morning for eight weeks. They complete weekly assessments and a final set after a short break.
- Time commitment
- About 12 weeks total: eight weeks of daily light sessions, a four‑week washout, and weekly clinic visits for assessments.
You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 and older
You may be able to join if
- Participants must be diagnosed with mild cognitive impairment or mild Alzheimer's disease, as defined by a Montreal Cognitive Assessment score...
- Have sleep disturbance indicated by a score \>5 on the Pittsburgh Sleep Quality Index
- Participants must reside in their homes, independent living, or assisted living facilities
You likely can't join if
- Participants taking sleep medication
- Residence in a skilled nursing facility or long-term care
- Obstructing cataracts, macular degeneration, and blindness
- Severe sleep apnea or restless leg syndrome
- History of severe epilepsy
The study team makes the final eligibility decision.
Where it is enrolling
- Menands, New York, United States
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Menands, New York, United States; New York, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.